<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-07-07" id="root" itemid="711117" xml:lang="en">
<title>USA: Procept names M. Weiss interim chairman.</title>
<headline>Procept names M. Weiss interim chairman.</headline>
<dateline>CAMBRIDGE, Mass. 1997-07-07</dateline>
<text>
<p>Procept Inc said Monday hat its board had elected Michael Weiss to the board as interim chairman.</p>
<p>Weiss is also the interim chairman of Genta Inc, and a director of AVAX Technologies Inc, Xytronyx Inc and Palatin Technologies Inc, each a publicly traded biotechnology company.</p>
<p>Procept is engaged in research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system disorders.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-07-07" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-07-07" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="CAMBRIDGE, Mass." />
<dc element="dc.creator.location.country.name" value="USA" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>